A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DNP / diabetic neuropathy

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DNP  (>> Co-occurring Abbreviation)
Long Form:   diabetic neuropathy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors. DM
2021 Alpha 1 adrenoceptor expression in skin, nerves and blood vessels of patients with painful diabetic neuropathy. alpha1-AR, SMP
2021 Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy. MCP-1, T2DM, UHS
2021 The impact of diabetic neuropathy on the distal versus proximal comparison of weakness in lower and upper limb muscles of patients with type 2 diabetes mellitus: a cross-sectional study. HC, IK, IM, T2DM
2021 Translation, validation, and diagnostic accuracy of the Arabic version of the Michigan neuropathy screening instrument. DNS, MNSI, MNSIq-Ar, mTCNS, SNA, UENS
2020 Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b. DEX, HG, VDR
2020 The impact of sensory and/or sensorimotor neuropathy on lower limb muscle endurance, explosive and maximal muscle strength in patients with type 2 diabetes mellitus. T2DM
2019 Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy). DEC, DM, EMG, ROC
2019 IGF-1 Via PI3K/Akt/S6K Signaling Pathway Protects DRG Neurons with High Glucose-induced Toxicity. DRG, IGF-1, ROS
10  2019 Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective. ---
11  2019 The Effect of Shear Force on Skin Viability in Patients with Type 2 Diabetes. DM
12  2017 Essential role of brain-derived neurotrophic factor (bdnf) in diabetic erectile dysfunction. BDNF, ED
13  2017 Nodes of Ranvier in skin biopsies of patients with diabetes mellitus. DM
14  2016 Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis. ALS, IGF-1, IGF-1R, IGFBPs
15  2016 LncRNA NONRATT021972 siRNA attenuates P2X7 receptor expression and inflammatory cytokine production induced by combined high glucose and free fatty acids in PC12 cells. FFAs, HGHF, lncRNAs, MAPK, siRNA
16  2016 Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy. DM, EMG, LEV, STZ
17  2016 Oxytocin provides protection against diabetic polyneuropathy in rats. EMG, OT
18  2015 Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy. IGF-1R, IGF1
19  2014 Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway. ATP, FFAs, IL, MAPK, mRNA, RESV
20  2013 Afferent control of walking: are there distinct deficits associated to loss of fibres of different diameter? CMT1A, CV
21  2013 High fatty acids modulate P2X(7) expression and IL-6 release via the p38 MAPK pathway in PC12 cells. FFAs, IL, MAPK
22  2011 Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. DM, IENFd, LEPs, QST
23  2009 [Clinical heterogeneity and coexistence of diabetic neuropathies: difference and similarities between types 1 and 2 diabetes mellitus]. CAN, CPP, PN
24  2006 High prevalence of diabetic polyneuropathy in a group of Brazilian children with type 1 diabetes mellitus. NC
25  2003 Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. CIDP, DM
26  2001 The change of insulin-like growth factor-1 in diabetic patients with neuropathy. IGF-1, RIA
27  1999 Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. CPT
28  1990 Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. DM, NGF, STZ